Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis

被引：0
|
作者：
Riederer, M. A. [1 ]
Crescence, L. [2 ]
Caroff, E. [1 ]
Hubler, F. [1 ]
Panicot-Dubois, L. [2 ]
Dubois, C. [2 ]
机构：
[1] Idorsia Pharmaceut Ltd, Allschwil, Switzerland
[2] Aix Marseille Univ, INSEAM 1263, INRAE 1260, C2VN, Marseille, France
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3819 / 3819
页数：1
相关论文
共 50 条
  • [31] Elinogrel, a reversible P2Y12 receptor antagonist for the treatment of acute coronary syndrome and prevention of secondary thrombotic events
    Oestreich, Julie H.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (03) : 340 - 348
  • [32] CLINICAL SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ACT-246475: A SELECTIVE REVERSIBLE P2Y12 RECEPTOR ANTAGONIST.
    Juif, P. -E.
    Boehler, M.
    Ufer, M.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S71 - S71
  • [33] Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor
    Schilling, Uta
    Dingemanse, Jasper
    Dobrow, Michael
    Baumann, Martine
    Riederer, Markus A.
    Juif, Pierre-Eric
    Ufer, Mike
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (06) : 755 - 766
  • [34] P2Y12 receptor in platelet activation
    Kim, Soochong
    Kunapuli, Satya P.
    PLATELETS, 2011, 22 (01) : 56 - 60
  • [35] Pharmacogenetics of P2Y12 receptor inhibitors
    Thomas, Cameron D. D.
    Williams, Alexis K. K.
    Lee, Craig R. R.
    Cavallari, Larisa H. H.
    PHARMACOTHERAPY, 2023, 43 (02): : 158 - 175
  • [36] Pharmacology of the platelet P2Y12 receptor
    von Kuegelgen, Ivar
    PURINERGIC SIGNALLING, 2018, 14 : S8 - S9
  • [37] Antiplatelet Therapy Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
    Mousa, Shaker A.
    Jeske, Walter P.
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (02) : 170 - 176
  • [38] Role of P2Y12 Receptor in Thrombosis
    Zhang, Yaqi
    Zhang, Si
    Ding, Zhongren
    THROMBOSIS AND EMBOLISM: FROM RESEARCH TO CLINICAL PRACTICE, VOL 1, 2017, 906 : 307 - 324
  • [39] Responsiveness to P2Y12 receptor inhibitors
    Esposito, Giovanni
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 : S31 - S37
  • [40] From ATP to AZD6140:: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis
    Springthorpe, Brian
    Bailey, Andrew
    Barton, Patrick
    Birkinshaw, Timothy N.
    Bonnert, Roger V.
    Brown, Roger C.
    Chapman, David
    Dixon, John
    Guile, Simon D.
    Humphries, Robert G.
    Hunt, Simon F.
    Ince, Francis
    Ingall, Anthony H.
    Kirk, Ian P.
    Leeson, Paul D.
    Leff, Paul
    Lewis, Richard J.
    Martin, Barrie P.
    McGinnity, Dermot F.
    Mortimore, Michael P.
    Paine, Stuart W.
    Pairaudeau, Garry
    Patel, Anil
    Rigby, Aaron J.
    Riley, Robert J.
    Teobald, Barry J.
    Tomlinson, Wendy
    Webborn, Peter J. H.
    Willis, Paul A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (21) : 6013 - 6018
12345